Medicus Pharma Ltd. Common Stock (MDCX) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Medicus Pharma Ltd. Common Stock in 2026. The next earnings report is expected on November 20, 2026.
Next earnings date
20 Nov 2026
In 92 days
EPS estimate
-0.11
Revenue estimate
0
Past earnings
Latest earnings analysis
Medicus Pharma missed consensus on EPS, with EPS of -$0.21 versus an estimate of -$0.1275, while revenue met expectations at $0.00. In the prior quarter EPS also missed expectations and revenue met estimates.
No dividend history available.
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
Medicus Pharma Ltd. Common Stock (MDCX) is scheduled to report earnings on November 20, 2026.
Medicus Pharma Ltd. Common Stock (MDCX) last reported earnings on August 12, 2026.
Medicus Pharma Ltd. Common Stock (MDCX) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.